MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2018 International Congress

    Sexual Dysfunction in Women with Parkinson’s Disease

    A. Hannoun, A. Deb, K. Smith (Worcester, MA, USA)

    Objective: To assess the prevalence and severity of sexual dysfunction (SD) in women with Parkinson’s Disease (PD) in comparison to general population (GP), highlight the…
  • 2018 International Congress

    Pain is correlated with other motor and non-motor symptom in Parkinson’s disease

    Y. Liu, X.Y. Zhu, X.J. Zhang, S.L. Yang, T.Y. Feng, Y.C. Wu (Shanghai, China)

    Objective: Study pain occurrence and appearance in Parkinson’s disease (PD), and its relationship with other motor and non-motor symptoms like constipation and footsteps. Background: The…
  • 2018 International Congress

    Validation of the French version of the Munich Dysphagia Test-Parkinson’s disease (MDT-PD) in a multilingual population of the Luxembourg Parkinson’s Study (HELP-PD)

    G. Hipp, M. Vaillant, P. Kolber, C. Pauly, L. Pavelka, D. Reiter, R. Krüger, J. Simons (Belvaux, Luxembourg)

    Objective: To provide the psychometric validation of the French MDT-PD in the Luxembourgish multilingual population. Background: The MDT-PD, developed and validated in German [1], is…
  • 2018 International Congress

    Stigma and communication in people with Parkinson’s disease (PPD)

    M. Bacigalupe (La Plata, Argentina)

    Objective: To present results about stigma in PPD from a Parkinson’s Workshop. These are preliminary results in the path to address the main project question…
  • 2018 International Congress

    B lymphocytes may be protective in early Parkinson’s disease and in an animal model of dopaminergic cell death

    K. Scott, C. Williams-Gray, R. Wijeyekoon, S. Hayat, K. Hall, P. Tyers, R. Mathews, R. Barker, M. Clatworthy (Cambridge, United Kingdom)

    Objective: To investigate B lymphocyte phenotype and function in human PD and in an animal model of disease. Background: The clinical course in Parkinson’s disease…
  • 2018 International Congress

    Red cell distribution with levels in Parkinson’s disease patients

    G. Ozgen Kenangil, B.C. Ari, F. Altuntas Kaya, M. Demir, F. Mayda Domac (Istanbul, Turkey)

    Objective: Parkinson’s Disease is a neurodegenerative disorder caused by oxidative stress, protein changes and mitochondrial disfunction. Lately, it has been suggested that inflammatory cytokine levels…
  • 2018 International Congress

    Clinical correlates of stuttering in advanced Parkinson’s disease

    T. Tsuboi, H. Watanabe, Y. Tanaka, R. Ohdake, M. Hattori, K. Kawabata, K. Hara, D. Nakatsubo, S. Maesawa, Y. Kajita, T. Wakabayashi, M. Katsuno, G. Sobue (Nagoya, Japan)

    Objective: We investigated clinical characteristics of a large number of advanced Parkinson’s disease (PD) patients to reveal risk factors for the development of stuttering and…
  • 2018 International Congress

    Executive dysfunctions and behavioral changes in early drug-naïve patients with Parkinson’s disease

    S. Li, R. Ou, X. Yuan, H. Liu, Y. Bing, Q. Wei, W. Song, B. Cao, Y. Chen, H. Shang (Chengdu, China)

    Objective: This study aims to explore the prevalence and onset age-related difference of executive dysfunctions and behavioral changes in drug-naïve patients with early stage of…
  • 2018 International Congress

    Differences in the Unified Dyskinesia Rating Scale based on age, Parkinson´s Disease and Dyskinesias duration

    E. Cubo, S. Luo, S. Calvo, P. Martinez-Martín (Burgos, Spain)

    Objective: To analyze the Unified Dyskinesia Rating Scale (UDysRS) scores on Historical, Objective parts and their differences based on age, Parkinson´s disease (PD) and dyskinesias…
  • 2018 International Congress

    Advanced Parkinson’s disease Diagnosis and Treatment Trends in Israel – Sub-Analysis of the OBSERVE-PD Multi-Country, Cross-Sectional Study

    R. Djaldetti, S. Hassin-Baer, M. Anca-Herschkovitsch, R. Gross, R. Cohen, H. Banayan, K. Onuk, T. Gurevich (Petah Tikva, Israel)

    Objective: The primary objective of this observational study was to evaluate the proportion of Parkinson’s disease (PD) patients identified as advanced PD (APD) patients according…
  • « Previous Page
  • 1
  • …
  • 230
  • 231
  • 232
  • 233
  • 234
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley